In addition, TERT promoter (TERTp) variants have been associated with a shorter time to progression in meningiomas [15] and have been included as an independent criterion for WHO grade 3 meningiomas in the 2021 WHO Classifications of Tumors of the Central Nervous System [16]. Here, TERT is linked to meningioma.